SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

S&P 100 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Biogen Idec Inc: Click to view the issuer\'s details

Last update : 21/08/2018  >View issuer details

2018.09.04 | 13:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Biogen Enrolls First Patient in Global Phase 3 Study of BIIB093 (IV Glibenclamide) for Large Hemispheric Infarction - HTML (w)

2018.08.28 | 13:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Biogen and Eisai Report Data from Long-Term Extension Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab - HTML (w)

2018.07.25 | 23:08 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Eisai and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimer's Disease at Alzheimer's Association International Conference (AAIC) 2018 - HTML (w)

2018.07.25 | 16:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Eisai and Biogen Present Detailed Results From Phase II Clinical Study of Elenbecestat in MCI and Mild to Moderate Alzheimer's Disease at Alzheimer's Association International Conference (AAIC) 2018 - HTML (w)

2018.07.18 | 13:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Data to be Presented From Biogen's Alzheimer's Disease Clinical Development Portfolio at the 2018 Alzheimer's Association International Conference (AAIC) - HTML (w)

2018.07.06 | 01:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months - HTML (w)

2018.06.28 | 22:06 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Biogen Exercises Option to Increase Ownership in Samsung Bioepis - HTML (w)

2018.06.13 | 13:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Biogen Enhances Commitment to SMA Research with Data Presented at Annual SMA Conference - HTML (w)

2018.06.07 | 13:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Biogen Enters Exclusive Option Agreement to Acquire TMS' Phase 2 Asset for Acute Stroke - HTML (w)

2018.05.31 | 13:30 | Permanent Information Releases / Appointments

English version HTML (w) Mail

puce Biogen Appoints Daniel Karp as EVP, Corporate Development - HTML (w)

2018.04.24 | Periodic information / 1st Quarter Information

English version PDF Mail

puce Biogen Idec Inc : First quarter 2018 - PDF (739Kb)

2018.02.01 | Periodic information / Annual Financial Report

English version PDF Mail

puce Biogen Idec Inc : Annual Report 2017 - Form 10K - PDF (8Mb)

2017.10.24 | Periodic information / 3rd Quarter Information

English version PDF Mail

puce Biogen Idec Inc : QUARTERLY REPORT for the quarterly period ended September 30, 2017 - Form 10-Q - PDF (5Mb)

2017.07.25 | Periodic information / Half-Year Financial Report

English version PDF Mail

puce Biogen Idec Inc : QUARTERLY REPORT for the quarterly period ended June 30, 2017 - Form 10-Q - PDF (5Mb)

2017.04.25 | Periodic information / 1st Quarter Information

English version PDF Mail

puce Biogen Idec Inc : Quarterly period ended March 31, 2017 - Form 10-Q - PDF (4Mb)

Pages : 1 - 2 / Doc nb : 27